Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium

F. Donohue, James; Fogarty, Charles; Lötvall, Jan; A. Mahler, Donald; Worth, H.; Yorgancıoğlu, Arzu; Iqbal, Amir; Swales, James; Owen, Roger; Higgins, Mark; Krämer, Benjamin

doi:10.1164/rccm.200910-1500oc

Public

Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium

Published in American Journal of Respiratory and Critical Care Medicine • May 12, 2010

Authors:

James F. Donohue

Charles Fogarty

Jan Lötvall

Abstract

RATIONALE: Indacaterol is the first once-daily, long-acting inhaled beta(2)-agonist bronchodilator studied in patients with chronic obstructive pulmonary disease (COPD). OBJECTIVES: To demonstrate greater efficacy of indacaterol versus placebo on FEV(1) at 24 hours post dose (trough) after 12 weeks,...

Subject

Indacaterol

Medicine

COPD

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!